Changes of Serum Soluble Receptor Activator for Nuclear Factor-κB Ligand after Glucocorticoid Therapy Reflect Regulation of Its Expression by Osteoblasts

CONTEXT: Osteoporosis is a serious complication of systemic glucocorticoid therapy. The role of serum soluble receptor activator for nuclear factor-κB ligand (RANKL) in glucocorticoid-induced osteoporosis remains unclear. OBJECTIVE: The objective of the study was to clarify the influence of serum so...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kaneko, Kaichi, Kusunoki, Natsuko, Hasunuma, Tomoko, Kawai, Shinichi
Materialtyp: Artigo
Språk:Inglês
Publicerad: Endocrine Society 2012
Ämnen:
Hot Topics in Translational Endocrinology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3462941/
https://ncbi.nlm.nih.gov/pubmed/22791764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-1971
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk